News

West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.

A paper examines how these droplets are transmitted and ways to protect these providers from COVID-19.

A modeling study from Imperial College shows the COVID-19 pandemic may require balancing with other infectious disease priorities.

The burden of COVID-19 is far reaching and a new study into excess mortality sheds light on this saddening topic.

Tens of thousands of patients were prescribed the anti-malarial drugs in the early weeks of the pandemic, a statistic that concerns public health officials.

Heparin may lower the odds of SARS-CoV-2 infection, according to investigators from the Rensselaer Polytechnic Institute.

Rajiv Dhand, MD, discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.

New study findings shed light on the positive effects of baloxavir for preventing influenza spread in household settings.

In Mbandaka, an 11th outbreak of Ebola is emerging. This outbreak has renewed questions about what makes the virus such a challenge for Congolese society to reign in.

Skilled nursing facilities are facing an unprecedented crisis as deaths rise amid the COVID-19 pandemic while admissions and patient census decline, a new study shows.

The mRNA-1273 vaccine candidate from Moderna will progress to a phase 3 trial in adults later this summer.

Why it's critical for the future of HIV prevention for programs like the California PrEP-AP to reach younger at-risk persons now.

A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.

In the second segment of the interview, Gilead’s Gelezinuas and SenGupta discuss the areas of unmet HIV therapy needs, cure research, and the benefits of a virtual conference.

A new study finds patients with Clostridium difficile infection are more likely to face a recurrence of the infection if they also have renal impairment. However, bezlotoxumab can reduce that risk.

A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.

How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.

Pfizer and BioNTech were given approval by the federal agency to expedite their work on investigational vaccines.

Gilead provides some important information on this investigational therapy.

Ebola virus disease definitions from the World Health Organization definitions could be improved by including contact history and intense fatigue as a key symptom and excluding fever, a new study found.

Efforts to develop a COVID-19 vaccine must not skip important steps during clinical evaluation, experts explain.

Is there an association with adverse outcomes in patients hospitalized with influenza taking NSAIDS?

Why men who have sex with men face social hurdles in seeking PrEP and preventive education.

How regional-based data and advancing preventive options could bolster individual HIV-risk care access.

Mylan Pharmaceuticals also announced that a batch of daptomycin has been recalled due to contamination.

Biopharmaceutical companies create nearly $1 billion fund to aid much needed pipeline for antimicrobial resistance.

Findings were announced during the special COVID-19 sessions of the virtual 23rd International AIDS Conference.

While household transmission of C diff infection is low, there was increased incidence after a familial exposure.